Translation from Research to Applications

Department of Biomedical Engineering, Columbia University, New York, New York, United States
Tissue Engineering (Impact Factor: 4.25). 01/2007; 12(12):3341-64. DOI: 10.1089/ten.2006.12.3341
Source: PubMed


The article summarizes the collective views expressed at the fourth session of the workshop Tissue Engineering--the Next Generation, which was devoted to the translation of results of tissue engineering research into applications. Ernst Hunziker described the paradigm of a dual translational approach, and argued that tissue engineering should be guided by the dimensions and physiological setting of the bodily compartment to be repaired. Myron Spector discussed collagen-glycosaminoglycan (GAG) scaffolds for musculoskeletal tissue engineering. Jeanette Libera focused on the biological and clinical aspects of cartilage tissue engineering, and described a completely autologous procedure for engineering cartilage using the patient's own chondrocytes and blood serum. Arthur Gertzman reviewed the applications of allograft tissues in orthopedic surgery, and outlined the potential of allograft tissues as models for biological and medical studies. Savio Woo discussed a list of functional tissue engineering approaches designed to restore the biochemical and biomechanical properties of injured ligaments and tendons to be closer to that of the normal tissues. Specific examples of using biological scaffolds that have chemoattractants as well as growth factors with unique contact guidance properties to improve their healing process were shown. Anthony Ratcliffe discussed the translation of the results of research into products that are profitable and meet regulatory requirements. Michael Lysaght challenged the proposition that commercial and clinical failures of early tissue engineering products demonstrate a need for more focus on basic research. Arthur Coury described the evolution of tissue engineering products based on the example of Genzyme, and how various definitions of success and failure can affect perceptions and policies relative to the status and advancement of the field of tissue engineering.

Download full-text


Available from: Ernst B Hunziker, Jan 10, 2014
  • Source
    • "(M. Lysaght, Brown University, quoted in [Hunziker et al., 2006]). What product features should the research field of tissue engineering focus on? "
    [Show abstract] [Hide abstract]
    ABSTRACT: The common technique of growing cells on tissue culture plastic (TCP) is gradually being supplanted by methods for culturing cells in two-dimensions (2-D) on matrices with more appropriate physical and biological properties or by encapsulation of cells in three-dimensions (3-D). The universal acceptance of the new 3-D paradigm is currently constrained by the lack of a biocompatible material in the marketplace that offers ease of use, experimental flexibility, and a seamless transition from in vitro to in vivo applications. In this Prospect, I argue that the standard for 3-D cell culture should be bio-inspired, biomimetic materials that can be used "as is" in drug discovery, toxicology, cell banking, and ultimately in medicine. Such biomaterials must therefore be highly reproducible, manufacturable, approvable, and affordable. To obtain integrated, functional, multicellular systems that recapitulate tissues and organs, the needs of the true end-users-physicians and patients-must dictate the key design criteria. Herein I describe the development of one such material that meets these requirements: a covalently crosslinked, biodegradable, simplified mimic of the extracellular matrix (ECM) that permits 3-D culture of cells in vitro and enables tissue formation in vivo. In contrast to materials that were designed for in vitro cell culture and then found unsuitable for clinical use, these semi-synthetic hyaluronan-derived materials were developed for in vivo tissue repair, and are now being re-engineered for in vitro applications in research.
    Preview · Article · Aug 2007 · Journal of Cellular Biochemistry
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cell adhesion process on solid biomatrices is demonstrated to influence dramatically the in vitro morphogenesis of artificial tissues, because it involves all the key factors of early tissue formation: cells, matrix and the physiological interactions between them. To evaluate the efficiency of this process, many authors proposed static parameters like final cell density, cell distribution, and final cell viability in different seeding techniques, i.e. static, circular flow or direct perfusion seeding. We studied the cell adhesion dynamics using a homemade optical density-meter under various experimental conditions. A modified fluorimetric cuvette was used where solid collagen type I matrices are exposed directly to the 3T3 murine cells under continuous agitation with a magnetic stirrer. The optical density data are digitally recorded by an optoelectronic device (Texas Instruments). Through computer processing, the variation of the cell suspension's concentration during the entire process can be observed, results being expressed either in optical density decrease per minute, or in number of cells seeded per minute. The experimental seeding curves were analyzed in terms of a sequential 2-phase kinetics model. Results showed a good correlation between prediction and experimental curves.
    Full-text · Article ·
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Strategies that utilize controlled release of drugs and proteins for tissue engineering have enormous potential to regenerate damaged organs and tissues. The multiple advantages of controlled release strategies merit overcoming the significant challenges to translation, including high costs and long, difficult regulatory pathways. This review highlights the potential of controlled release of proteins for tissue engineering and regenerative medicine. We specifically discuss treatment modalities that have reached preclinical and clinical trials, with emphasis on controlled release systems for bone tissue engineering, the most advanced application with several products already in clinic. Possible strategies to address translational and regulatory concerns are also discussed.
    Full-text · Article · Feb 2013 · Drug Delivery and Translational Research
Show more